| Primary information |
|---|
| CancerPPD ID | 3841 |
| PMID | 20515045 |
| YEAR | 2010 |
| SEQUENCE | ACDCRGDCFCGGGGIVRRADRAAVP |
| LENGTH | 25 |
| NAME | AP(O) |
| C-ter Modification | Free |
| N-ter Modification | Free |
| Linear/Cyclic | Cyclic(C2-C10,C |
| L/D/Mix | L |
| Non-Natural | None |
| NATURE | Antitumor |
| ACTIVITY | 42% inhibition at 5µg/ml |
| SOURCE | Endostatin derived synthetic peptide |
| Cancer Type | Tumor |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Not Available |
| CELL LINE | BAE |
| TEST TIME | NA |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | CCSTTTTCTTTGGGSTTCCCCCSCC |
| SMILES | N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|